Hide Board Information

Show Board Information

Biora Therapeutics, Inc. BIORQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/22/2023 6:06:38 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 16

Biora Therapeutics, Inc. (OTCMRKTS: BIORQ) Stock Message Board

1. BIORQ Company Profile

    

2. BIORQ Time & Sales

    

3. BIORQ Recent News

    

4. BIORQ Filings

    

5. BIORQ Financials

    

6. BIORQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$BIOR 31% v1,5M c4.85 f11,859M H5.10 ML2.26	znewcar1	05/22/2023 6:06:38 PM
5	$BIOR 155% v50,1M c5.40 f8,926M H5.63 ML1.95 off	znewcar1	01/10/2023 4:43:02 PM
4	BIOR 31% v30,9M c1.01 f184,2M H1.15 ML.6211	znewcar1	08/10/2022 5:36:14 PM
3	@1.28 still a bear	znewcar1	02/23/2022 1:30:51 PM
2	H2.11 @ 1.5 ML@1.11 downward slide (1)	znewcar1	02/18/2022 1:19:36 PM
1	PROG Stock Chart Video Analysis 02-08-2022	Chasing Stars	02/08/2022 8:14:59 PM

Recent Articles

• Exploring Undervalued Stocks Using the Stock Whisper Index
• Exploring the Growth of Atherectomy Devices and Market Trends
• Exploring the Future of the Spin on Carbon Market Growth
• Investigation into Elevance Health: A Call for Investors
• West Pharmaceutical Services Positioned for Strong Recovery Amid Lawsuit
• Compass Diversified Faces Legal Scrutiny: A Call to Investors
• IOV Investors: Join the Iovance Biotherapeutics Litigation
• BAY Miner Enhances Cloud Mining Services for Cryptocurrency Investors
• Important Update for Compass Diversified Holdings Investors
• Investigation into Vera Bradley, Inc. Sparks Legal Opportunities
• Investors with Losses in Civitas Resources Can Take Action Now
• Investors Can Step Forward in the DoubleVerify Legal Case
• Organon Investors Eye Legal Action Amid Possible Fraud Claims
• Investors Encouraged to Engage in PepGen Litigation Actions
• Navigating the Fortrea Holdings Investor Lawsuit Landscape
• XY Miners Launches Innovative Crypto Mining Platform for All
• Rocket Pharmaceuticals Faces Legal Challenge Over Securities Fraud
• Melinda French Gates Emphasizes Sports for Women's Success in Leadership
• AOFAR Unveils GX6: Affordable and Innovative Golf Rangefinder
• Cloud Solutions Propel Microservices in Healthcare Sector Growth
• Organon Faces Securities Fraud Allegations Amid Dividend Cuts
• Seize the Moment: Open Lending Securities Class Action Insights
• Krispy Kreme Investors: Join the Class Action Against Misleading Practices
• Understanding the Red Cat Holdings Legal Maneuvers: RCAT Insights
• Tech Stocks Rally: Nvidia and Micron Lead Market Surge
• Legal Action Initiated Regarding Employer-Tying Regulations
• Class Action Lawsuit Challenges Employment Restrictions for Workers
• Investors of Apple Inc. Urged to Act Amid Legal Action News
• Securities Fraud Allegations Against Iovance Biotherapeutics
• Recent Securities Fraud Action Against Hims & Hers Health, Inc.
• Reddit, Inc. Faces Legal Action from Investors – Join the Fight Now
• Fortrea Holdings Inc.: Legal Challenges and Investor Impact
• Civitas Resources Faces Legal Challenges Amid Securities Concerns
• Compass Diversified Holdings Faced with Serious Legal Challenges
• Final Countdown: Join the $VLT Presale Before It Ends!
• Unveil Your Style with Luvme Hair's Patriotic Wig Discounts
• DXL Expands Presence with New Store Opening in Selma
• Warren Buffett's Generous Donation of $6 Billion to Charity
• TCL Electronics Celebrates Five Awards at HKIRA Investor Relations
• DAHON Revolutionizes Cycling with Innovative Tech at Eurobike
• Understanding the Influence of Trump's Fiscal Policies on Debt
• Aligning Financial Strategies with Personal Aspirations
• Navigating Trading Risks: Expert Tips for Success
• Xlence's Role as Diamond Sponsor at Trading Show 2025
• Xlence Takes Center Stage at The Trading Show 2025 in Casablanca
• Investors Encouraged to Join Class Action Against Vestis Corp
• Gregg Alexander's Iconic Comeback with BMI Pop Award Recognition
• JBS USA Food Company's Successful Tender Offer for Notes
• Understanding Recent Allegations Against Rocket Pharmaceuticals Inc
• Understanding Class Action Options for Tempus AI Inc (TEM) Investors